Stay updated on Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the study completion date for the clinical trial assessing the efficacy of Pembrolizumab Plus Radiotherapy in Metastatic Triple Negative Breast Cancer Patients.
    Difference
    0.1%
    Check dated 2024-06-06T14:28:13.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to a more detailed description, now stating 'Researchers look for people who fit a certain description, called eligibility criteria,' and providing examples such as a person's general health condition or prior treatments.
    Difference
    53%
    Check dated 2024-05-22T21:29:56.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:33:07.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page.